[Federal Register: February 20, 2003 (Volume 68, Number 34)]
 [Notices]
 [Page 8299-8300]
 From the Federal Register Online via GPO Access [wais.access.gpo.gov]
 [DOCID:fr20fe03-68]
 
 -----------------------------------------------------------------------
 
 DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
 Food and Drug Administration
 
 Contaminants and Natural Toxicants Subcommittee of the Food
 Advisory Committee; Notice of Meeting
 
 AGENCY: Food and Drug Administration, HHS.
 
 ACTION: Notice.
 
 -----------------------------------------------------------------------
 
     This notice announces a forthcoming meeting of a public advisory
 committee of the Food and Drug Administration (FDA). The meeting will
 be open to the public.
     Name of Committee: Contaminants and Natural Toxicants Subcommittee
 of the Food Advisory Committee.
     General Function of the Committee: To provide advice and
 recommendations to the agency on FDA's regulatory issues.
     Date and Time: The meeting will be held on March 18, 2003, from 8
 a.m. to 6 p.m.; and on March 19, 2003, from 8:30 a.m. to 3 p.m.
     Location: U.S. Department of Agriculture, Animal and Plant Health
 Inspection Service, 4700 River Rd., Conference Center, Riverdale, MD,
 301-734-8010.
     Contact Person: Jeanne E. Latham, Center for Food Safety and
 Applied Nutrition (HFS-800), Food and Drug Administration, 5100 Paint
 Branch Pkwy., College Park, MD 20740, 301-436-1756, or FDA Advisory
 Committee Information Line, 1-800-741-8138 301-443-0572 in the
 Washington, DC area), code 10564. Please call the Information Line for
 up-to-date information on this meeting.
     Agenda: The meeting's purpose is to discuss the scientific issues
 and principles involved in assessing and evaluating Enterobacter
 sakazakii contamination in powdered infant formula, risk reduction
 strategies based on available data, and research questions and
 priorities. To ensure the presence of the most relevant expertise, the
 membership of the subcommittee, which has expertise in contaminants,
 will be augmented by consultants with expertise in infant formula.
     The background material for this meeting will be posted on the
 Internet when available or one working day before the meeting at http://www.cfsan.fda.gov/
 [sim]lrd/vidtel.html.
     Procedure: Interested persons may present data, information, or
 views, orally or in writing, on issues pending before the committee.
 Written submissions may be made to the contact person by March 3, 2003.
 Oral
 
 [[Page 8300]]
 
 presentations from the public will be scheduled between approximately 4
 p.m. and 5 p.m. on March 18, 2003. Time allotted for each presentation
 may be limited. Those desiring to make formal oral presentations should
 notify the contact person before March 13, 2003, and submit a brief
 statement of the general nature of the evidence or arguments they wish
 to present, the names and addresses of proposed participants, and an
 indication of the approximate time requested to make their
 presentation.
     Persons attending FDA's advisory committee meetings are advised
 that the agency is not responsible for providing access to electrical
 outlets.
     FDA welcomes the attendance of the public at its advisory committee
 meetings and will make every effort to accommodate persons with
 physical disabilities or special needs. If you require special
 accommodations due to a disability, please contact Jeanne E. Latham at
 least 7 days in advance of the meeting.
     Notice of this meeting is given under the Federal Advisory
 Committee Act (5 U.S.C. app. 2).
 
     Dated: February 10, 2003.
 Linda Arey Skladany,
 Associate Commissioner for External Relations.
 [FR Doc. 03-4089 Filed 2-19-03; 8:45 am]
 
 BILLING CODE 4160-01-S